Q2017 Injection, teniposide, 50 mg

Short descriptor: Teniposide, 50 mg

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q2017 was terminated as of 2025-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q2017 in the app →

Look up Q2017 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q2017 is the HCPCS Level II code for Injection, teniposide, 50 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2026-01-01
Termination Date
2025-12-31
2026 Maintenance
Discontinued

References

Cite This Page

Reference Q2017 with the canonical source and edition:

Q2017 — Injection, teniposide, 50 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q2017

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q2017

Related Codes in Section Q

← Q2009 Fosphenytoin inj pe Q2026 → Radiesse injection
Q1004 Ntiol category 4 Q1005 Ntiol category 5 Q2004 Bladder calculi irrig sol Q2009 Fosphenytoin inj pe Q2026 Radiesse injection Q2028 Inj, sculptra, 0.5mg Q2034 Agriflu vaccine Q2035 Afluria vacc, 3 yrs & >, im Q2036 Flulaval vacc, 3 yrs & >, im Q2037 Fluvirin vacc, 3 yrs & >, im
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial